Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Julie A. Panepinto, MD, MSPH
Researcher Director
Division of Blood Diseases and Resources (DBDR)
National Heart, Lung, and Blood Institute
of the National Institutes of Health
Building 31, 31 Center Drive
Bethesda, Maryland, United States
Julie Panepinto is the Director of the Division of Blood Diseases and Resources (DBDR) at the National Heart, Lung, and Blood Institute of the National Institutes of Health.
Prior to joining the NHLBI in June 2021, as the Deputy Director of DBDR, Dr. Panepinto was a tenured Professor of Pediatrics, Hematology, Vice Chair of Value in Pediatrics, and the Director of the Center for Clinical Effectiveness Research of the Children’s Research Institute at the Medical College of Wisconsin and Children’s Wisconsin. As a clinician researcher with a background in public health, Dr. Panepinto focused her academic career on understanding and improving the health outcomes of patients and families with chronic diseases. Her research focused on integrating the perspective of the patient and family in health care through the use of patient reported outcomes (PROs) and understanding systems of care and acute care utilization for those individuals living with sickle cell disease.
Dr. Panepinto completed her fellowship in Pediatric Hematology/Oncology/Bone Marrow Transplant at the University of Colorado Health Sciences in Denver, Colorado, where she also earned a Master of Science in Public Health. She served as a past member on the NHLBI Data and Safety Monitoring Board (DSMB) for the Sickle Cell Disease Clinical Research Network (2006-2010), the NHLBI’s Sickle Cell Disease Advisory Committee from 2016-2019, and the Advisory Council for the NHLBI from 2020-2021.
+myBinderRelated Content
-
Global Sickle Cell Disease Treatment Market 2019–2023| Evolving Opportunities with ADDMEDICA and Bristol-Myers Squ...The global sickle cell disease treatment...
-
Sancilio Pharmaceuticals Company, Inc. Announces Completion of Enrollment in the SCOT Trial in Pediatric Patients Wi...Sancilio Pharmaceuticals Company, Inc. (...
-
Punam Malik, MDDr. Punam Malik is a pediatric hematolog...
-
University of Illinois at Chicago awarded $4.6 million NIH grant for chronic pain researchThe University of Illinois at Chicago ha...
-
The first two years of life in sickle cell anemia infants: A results of a comprehensive longitudinal studyInfancy is a critical time during which ...
-
Methodist Comprehensive Sickle Cell CenterMethodist Comprehensive Sickle Cell Cent...
-
Acute Care Utilization in Pediatric Sickle Cell Disease and Sickle Cell Trait in the USA: Prevalence, Temporal Trend...The objective of this study was to analy...
